Navigation Links
Drug Reduces Risk of Clogged Arteries, Veins

The blood-thinning drug fondaparinux (Arixta) nearly halves the risk of potentially deadly deep vein thrombosis and pulmonary embolism in people hospitalized with congestive heart failure, chronic respiratory disease and other conditions that increase the risk of these conditions, claims a new study.
People treated with the drug were 47 percent less likely to suffer venous thromboembolism (a condition involving clotting or obstruction of a vein that includes both deep vein thrombosis and pulmonary embolism) than people who received a placebo,// according to the study results. In the group taking fondaparinux, 5.6 percent had venus thromboembolism events, compared with 10.5 percent of the people in the placebo group.

The study also found that the drug reduced fatal pulmonary embolisms and showed a trend toward reducing overall death - 3.3 percent in the study group compared with 6 percent in the placebo group. The incidence of bleeding in both groups was 0.2 percent.

Page: 1

Related medicine news :

1. Sunshine Reduces MS Risk
2. Estrogen in Food Reduces Cancer Risk
3. Dental Procedure Reduces Preterm Births
4. Vaccine Reduces antibiotic-resistant infections in Children
5. Eating Fiber Reduces The Risk Of Heart Disease
6. Higher Statin Dose Safely Reduces Stroke and Cardiac Arrest
7. Anti-tobacco Advertising Can Reduces smoking Among Teens
8. Eating Fish Reduces Heart Disease
9. Co-trimoxazole Use Reduces Childhood AIDS –Related Death
10. NSAIDS, Reduces The Risk Of Oral Cancer But Causes Heart Attacks
11. Oxytocin Boosts Trust and Reduces Fear.
Post Your Comments:

(Date:6/25/2016)... Viejo, California (PRWEB) , ... June 25, 2016 , ... ... to fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... fully customizable and all within Final Cut Pro X . Simply select a ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out ... family verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers ... would throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile technology, ... , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can be ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Issue 52" report to their offering. ... treatment creates a favourable commercial environment for MedImmune to enter. ... base that will serve to drive considerable growth for effective ... serve to cap sales considerably, but development is still in ...
(Date:6/23/2016)... 2016 , , , WHEN: ... 2016 , , , , LOCATION: , , , Online, ... , , EXPERT PANELISTS:  , , , Frost & Sullivan,s Global ... Bird; Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager ... pharmaceutical industry is witnessing an exceptional era. Several new demand spaces, ...
(Date:6/23/2016)... the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in Bogota. Colombia ... ... Sandra ... ... Astellas is a pharmaceutical company ...
Breaking Medicine Technology: